Skip navigation

Senate resumes debate on SC's $5.8B spending plan

South Carolina Medicaid patients with AIDS, cancer or mental illness will have to use generic drugs if available under a budget measure the Senate agreed to Tuesday. Full story

Medco Health Solutions 1Q profit rises 4 percent

Pharmacy benefits manager Medco Health Solutions Inc. said Thursday its profit rose 4 percent in the first quarter on an increase in the volume of mail-order generic drug prescriptions and retail prescriptions. Full story

Mylan launches generic version of Femara

Generic drugmaker Mylan Inc. said Monday it has launched a generic version of Novartis' breast cancer treatment Femara. Full story

ViroPharma loses challenge to generic drug rule

Shares of biopharmaceutical company ViroPharma Inc. fell Monday after the company said a U.S. District Court ruled against it in a challenge to an FDA decision. Full story

Senate committee rejects requiring generic drugs

Senate budget writers Wednesday rejected an effort to require generic drugs for HIV/AIDS and mental health patients covered by the state's Medicaid programs. Full story

Endo Pharma buying American Medical for $2.6B

Endo Pharmaceuticals Holdings Inc. said Monday that it is buying urology and pelvic health company American Medical Systems Inc. for about $2.6 billion, expanding its medical device business. Full story

Sponsored Links


Fewer fill "dispense as written" prescriptions: study

Long-term tamoxifen boosts breast cancer survival

Supreme Court won't review drug patent deal

Seniors save as Medicare 'doughnut hole' closes

Blood drug could many save lives in combat, trauma

Study backs Novartis hypertension drug combination

Supreme Court to decide generic drug labeling issue

Many doctors ignore heart drug guidelines

Prescription drug use in U.S. fell last year

FDA: India drug makers lied about test results


  The Future of Generic Drugs

Discussing the opportunity for generic drug makers to make big profits, with Heather Bresch, Mylan president.

  Teva Acquires Ratiopharm

Teva announces it beat out Pfizer in a $5B deal for a privately held generic drug-maker in Germany, with William Marth, Teva Pharmaceutical North America CEO and CNBC's Mike Huckman.

  Spotlight on Generic Drugs From India

Satish Reddy, Dr. Reddy's Labs COO, discusses the generic drug business with CNBC's Mike Huckman.

  Windfall on Horizon for Generic Drug Industry?

Almost $150 billion worth of brand-name prescription drugs will lose their patents over the next five years. Kathleen Jaegar, president and CEO of the Generic Pharmaceutical Association, tells CNBC's Mike Huckman what this will mean for generic drug co...

  How safe are generic drugs?

May 26: According to the Congressional Budget Office, generic drugs save consumers at least $8 billion every year, but are they always the best choice? NBC’s chief medical editor Dr. Nancy Snyderman reports on the risks and benefits associated with generics.

advertisement | ad info

Related Photos

Pharmacy Offers Steep Discounts On Prescription Medication
Pharmacy Offers Steep Discounts On Prescription Medication

GLENSIDE, PA - SEPTEMBER 7: Pharmacist Howard Brooker fills a prescription at Adams Discount Pharmacy September 7, 2006 in Glenside, Pennsylvania. Adams offers generic drugs for forty to seventy five percent cheaper than the brand name manufacturer's cost. They are able to charge low prices by not